Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Medicale (MCLE) Return on Equity (2021 - 2025)

Medicale's Return on Equity history spans 5 years, with the latest figure at 0.2% for Q2 2025.

  • For Q2 2025, Return on Equity changed N/A year-over-year to 0.2%; the TTM value through Jun 2025 reached 0.2%, changed N/A, while the annual FY2023 figure was 0.01%, 9.0% down from the prior year.
  • Return on Equity reached 0.2% in Q2 2025 per MCLE's latest filing, up from 0.18% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 6.33% in Q3 2021 to a low of 0.01% in Q3 2023.
  • Average Return on Equity over 5 years is 0.74%, with a median of 0.16% recorded in 2025.
  • Peak YoY movement for Return on Equity: plummeted -628bps in 2022, then fell -6bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 1.2% in 2021, then crashed by -97bps to 0.04% in 2022, then crashed by -134bps to 0.01% in 2023, then soared by 1132bps to 0.14% in 2024, then skyrocketed by 41bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Return on Equity are 0.2% (Q2 2025), 0.18% (Q1 2025), and 0.14% (Q4 2024).